Progesterone sensitizes breast cancer MCF7 cells to imatinib inhibitory effects

Journal of Cellular Biochemistry

Volumn 103, Issue 2, 2008, Pages 607-614

  Rocha, Ana ^a   Azevedo, Isabel ^a   Soares, Raquel ^a  

^a University of Porto   (Portugal)

Author keywords

Breast cancer; Hormonal signaling; Imatinib; PDGF; Progesterone; Tyrosine kinase

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; IMATINIB; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROGESTERONE; PROTEIN TYROSINE KINASE;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL GROWTH; CELL MIGRATION; CELL STRAIN MCF 7; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; DRUG SYNERGISM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; PHOSPHORYLATION; PIPERAZINES; PROGESTERONE; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; TUMOR STEM CELL ASSAY;

EID: 38649127873     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21432     Document Type: Article

References (19)

1. Alvarez RH, Kantarjian HM, Cortes JE. 2006. Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc 81(9):1241-1257.
2. Buchdunger E, O'Reilly T, Wood J. 2002. Pharmacology of Imatinib (STI571). Eur J Cancer 38(5):S28-S36.
3. Carvalho I, Milanezi F, Martins A, Reis RM, Schmitt F. 2005. Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression. Breast Cancer Res 7(5):R788-R795.
4. Faivre EJ, Lange CA. 2006. Progesterone Receptors Up-regulate Wnt-1 to Induce EGFR transactivation and c-Src dependent sustained activation of Erk1/2 MAP Kinase in Breast Cancer Cells. Mol Cell Biol 27(2):466-480.
5. George D. 2001. Platelet-derived growth factor receptors: A therapeutic target in solid tumors. Semin Oncol 28 (5 Suppl 17):27-33.
6. Gonzales-Angulo AM, Hortobágyi GN, Esteva FJ. 2006. Adjuvant therapy with trastuzumab for HER-2/neu-Positive Breast Cancer. Oncologist 11:857-867.
7. Jechlinger M, Sommer A, Moriggl R, Seither P, Kraut N, Capodiecci P, Donovan M, Cordon-Cardo C, Beug H, Grunert S. 2006. Autocrine PDGFR signaling promotes mammary cancer metastasis. J Clin Invest 116(6):1561-1570.
8. Jones RL, Judson IR. 2005. The development and application of imatinib. Expert Opin Drug Saf 4(2):183-191.
9. Kantarjian HM, Cortes J. 2006. New strategies in chronic myeloid leukemia. Int J Hematol 83(4):289-293.
10. Mauro MJ, Druker BJ. 2001. ST 1571: Targeting BCR-ABL as therapy for CML. Oncologist 6(3):233-238.
11. Mittal A, Pate MS, Wylie RC, Tollefsbol TO, Katiyar SK. 2004. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int J Oncol 24:703-710.
12. Modi S, Seidman AD, Dickler M, Moasser M, D'Andrea G, Moynahan ME, Menell J, Panageas KS, Tan LK, Norton L, Hudis CA. 2005. A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer. Breast Cancer Res Treat 90(2):157-163.
13. Ostman A. 2004. PDGF receptors-meditors of autocrine tumor growth and regulators of tumor vasculature and stroma. Cytokine Growth Factor Rev 15:275-286.
14. Panigrahi I, Naithani R. 2006. Imatinib mesylate: A designer drug. J Assoc Physicians India 54:203-206.
15. Radford IR. 2002. Imatinib. Novartis. Curr Opin Investig Drugs 3(3):492-499.
16. Roussidis AE, Mitropoulou TN, Theocharis AD, Kiamouris C, Papadopoulos S, Kletsas D, Karamanos NK. 2004. STI571 as a potent inhibitor of growth and invasiveness of human epithelial breast cancer cells. Anticancer Res 24(3a):1445-1447.
17. Soares R, Guerreiro S, Botelho M. 2007. Elucidating progesterone effects in breast cancer: Cross talk with PDGF signalling pathway in smooth muscle cells. J Cell Biochem 100:174-183.
18. Tallquist M, Kazlauskas A. 2004. PDGF signaling in cells and mice. Cytokine Growth Factor Rev 15(4):205-213.
19. Tuveson DA, Willis NA, Jacks T, Griffin JD, Singer S, Fletcher CD, Fletcher JA, Demetri GD. 2001. STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: Biological and clinical implications. Oncogene 16,20(36):5054-5058.